Home

рекламирам домакиня пътешествие polo like kinase 4 посвещавам Отговорете спирала

Polo-like kinases: structural variations lead to multiple functions |  Nature Reviews Molecular Cell Biology
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology

Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab
Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab

Figure 3 from Polo-like kinase 4: the odd one out of the family | Semantic  Scholar
Figure 3 from Polo-like kinase 4: the odd one out of the family | Semantic Scholar

Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of  lung cancers | PNAS
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers | PNAS

Depletion of polo-like kinase (PLK)4 in mouse oocytes caused the... |  Download Scientific Diagram
Depletion of polo-like kinase (PLK)4 in mouse oocytes caused the... | Download Scientific Diagram

Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS
Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS

Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research
Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research

Molecular and structural basis of polo-like kinase 1 substrate recognition:  Implications in centrosomal localization | PNAS
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization | PNAS

PLK Inhibition | PLK Activation | PLK Inhibitor Review
PLK Inhibition | PLK Activation | PLK Inhibitor Review

Polo-like Kinase 4 Autodestructs by Generating Its Slimb-Binding  Phosphodegron - ScienceDirect
Polo-like Kinase 4 Autodestructs by Generating Its Slimb-Binding Phosphodegron - ScienceDirect

APExBIO - CFI-400945 orally available, selective inhibitor of polo-like  kinase 4 (PLK4) | CAS# 1338800-06-8
APExBIO - CFI-400945 orally available, selective inhibitor of polo-like kinase 4 (PLK4) | CAS# 1338800-06-8

PDF) Polo-like kinase 4: The odd one out of the family
PDF) Polo-like kinase 4: The odd one out of the family

Targeting polo-like kinase 1 for cancer therapy | Nature Reviews Cancer
Targeting polo-like kinase 1 for cancer therapy | Nature Reviews Cancer

Goat anti-Human PLK4 antibody (ABIN184701)
Goat anti-Human PLK4 antibody (ABIN184701)

Role for polo-like kinase 4 in mediation of cytokinesis | PNAS
Role for polo-like kinase 4 in mediation of cytokinesis | PNAS

PDF) Polo-like kinase 4 activity limits centrosome overduplication by  autoregulating its own stability
PDF) Polo-like kinase 4 activity limits centrosome overduplication by autoregulating its own stability

Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy? - ppt download
Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy? - ppt download

Localization and expression of polo-like kinase (PLK)4 during meiotic... |  Download Scientific Diagram
Localization and expression of polo-like kinase (PLK)4 during meiotic... | Download Scientific Diagram

Role for polo-like kinase 4 in mediation of cytokinesis | PNAS
Role for polo-like kinase 4 in mediation of cytokinesis | PNAS

The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? |  Cancer Research
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? | Cancer Research

Figure 2 from Polo-like kinase 4: the odd one out of the family | Semantic  Scholar
Figure 2 from Polo-like kinase 4: the odd one out of the family | Semantic Scholar

PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma  Associates with Poor Prognosis
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis

Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer  Therapy, with a Focus on NSCLC | Clinical Cancer Research
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research

PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma  Associates with Poor Prognosis
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis